T1	CHEM 97 105	propofol
#1	AnnotatorNotes T1	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T2	PROC 162 188	Análisis de la efectividad
T3	DISO 214 222	doloroso
#2	AnnotatorNotes T3	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T4	CHEM 254 262	propofol
#3	AnnotatorNotes T4	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T5	DISO 312 320	dolorosa
#4	AnnotatorNotes T5	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T6	PROC 324 332	inyectar
#5	AnnotatorNotes T6	C1533685; Injection procedure; Therapeutic or Preventive Procedure
T7	CHEM 333 341	propofol
#6	AnnotatorNotes T7	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T8	CHEM 424 432	Propofol
#7	AnnotatorNotes T8	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T9	CHEM 445 451	agente
#8	AnnotatorNotes T9	C0450442; Agent; Chemical Viewed Functionally
T10	PROC 481 505	mantenimiento anestésico
T11	PROC 532 544	intervención
#9	AnnotatorNotes T11	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T12	CHEM 724 732	propofol
#10	AnnotatorNotes T12	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T13	PROC 949 961	anestesiados
#11	AnnotatorNotes T13	C0002903; Anesthesia procedures; Therapeutic or Preventive Procedure
T14	PROC 979 986	cirugía
#12	AnnotatorNotes T14	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T15	PROC 991 1026	procedimientos de anestesia general
T16	PROC 1061 1085	consentimiento informado
#13	AnnotatorNotes T16	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T17	DISO 1148 1180	enfermedades renales o hepáticas
T18	DISO 1235 1247	intolerancia
#14	AnnotatorNotes T18	C0277585; Intolerance to drug; Pathologic Function
T19	DISO 1181 1188	Alergia
#15	AnnotatorNotes T19	C1527304; Allergic Reaction; Pathologic Function
T20	CHEM 1216 1224	propofol
#16	AnnotatorNotes T20	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T21	DISO 1225 1232	Alergia
#17	AnnotatorNotes T21	C1527304; Allergic Reaction; Pathologic Function
T22	CHEM 1260 1269	fentanilo
#18	AnnotatorNotes T22	C0015846; fentanyl; Organic Chemical · Pharmacologic Substance
T23	DISO 1270 1277	Alergia
#19	AnnotatorNotes T23	C1527304; Allergic Reaction; Pathologic Function
T24	CHEM 1307 1316	lidocaína
#20	AnnotatorNotes T24	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T25	PROC 1345 1369	consentimiento informado
#21	AnnotatorNotes T25	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T26	PROC 236 250	administración
#22	AnnotatorNotes T26	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T27	PROC 383 397	administración
#23	AnnotatorNotes T27	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T28	PROC 469 478	inducción
#24	AnnotatorNotes T28	C0857127; Induction procedure; Therapeutic or Preventive Procedure
T29	PROC 557 571	administración
#25	AnnotatorNotes T29	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T30	DISO 623 628	dolor
#26	AnnotatorNotes T30	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T31	PROC 649 658	inyección
#27	AnnotatorNotes T31	C1533685; Injection procedure; Therapeutic or Preventive Procedure
T32	DISO 807 812	dolor
#28	AnnotatorNotes T32	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T33	PROC 828 842	administración
#29	AnnotatorNotes T33	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T34	ANAT 1171 1180	hepáticas
#30	AnnotatorNotes T34	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T35	ANAT 1161 1168	renales
#31	AnnotatorNotes T35	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T36	DISO 1191 1203	intolerancia
#32	AnnotatorNotes T36	C0277585; Intolerance to drug; Pathologic Function
T37	DISO 1280 1292	intolerancia
#33	AnnotatorNotes T37	C0277585; Intolerance to drug; Pathologic Function
T38	Date 13 17	2018
T39	Route 106 117	intravenoso
#34	AnnotatorNotes T39	C1522726; Intravenous Route of Drug Administration; Functional Concept
T40	Route 200 210	endovenoso
#35	AnnotatorNotes T40	C1522726; Intravenous Route of Drug Administration; Functional Concept
T41	Neg_cue 211 213	no
T42	Neg_cue 309 311	no
T43	Route 452 463	intravenoso
#36	AnnotatorNotes T43	C1522726; Intravenous Route of Drug Administration; Functional Concept
T44	Neg_cue 520 531	sin ninguna
T48	LIVB 869 893	Pacientes de ambos sexos
#37	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group + C0025266; Male population group; Population Group + C0043210; Woman; Population Group
T49	Age 894 912	entre 18 y 65 años
T50	LIVB 925 934	pacientes
#38	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	LIVB 1040 1049	Pacientes
#39	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	Neg_cue 1317 1333	Incapacidad para
T45	Spec_cue 777 779	si
A1	Assertion T3 Negated
A2	Assertion T5 Negated
A3	Assertion T11 Negated
A4	Assertion T32 Speculated
A5	Assertion T25 Negated
A6	Status T36 History_of
A7	Status T19 History_of
A8	Status T21 History_of
A9	Status T18 History_of
A10	Status T37 History_of
A11	Status T23 History_of
#40	AnnotatorNotes T10	C0853213; Maintenance of anaesthesia; Therapeutic or Preventive Procedure 
#41	AnnotatorNotes T15	C0002915; General Anesthesia; Therapeutic or Preventive Procedure
#42	AnnotatorNotes T17	C0023895; Liver diseases; Disease or Syndrome + C0022658; Kidney Diseases; Disease or Syndrome
R1	Speculation Arg1:T45 Arg2:T32	
R2	Before Arg1:T33 Arg2:T32	
R3	Has_Route_or_Mode Arg1:T1 Arg2:T39	
R4	Negation Arg1:T41 Arg2:T3	
R5	Used_for Arg1:T4 Arg2:T26	
R6	Has_Route_or_Mode Arg1:T4 Arg2:T40	
R7	Before Arg1:T26 Arg2:T3	
R8	Negation Arg1:T42 Arg2:T5	
R9	Used_for Arg1:T7 Arg2:T6	
R10	Used_for Arg1:T7 Arg2:T27	
R11	Before Arg1:T6 Arg2:T5	
R12	Before Arg1:T27 Arg2:T5	
R13	Has_Route_or_Mode Arg1:T9 Arg2:T43	
R14	Has_Route_or_Mode Arg1:T8 Arg2:T43	
R15	Used_for Arg1:T8 Arg2:T28	
R16	Used_for Arg1:T8 Arg2:T10	
R17	Before Arg1:T28 Arg2:T10	
R18	Negation Arg1:T44 Arg2:T11	
R19	Before Arg1:T11 Arg2:T29	
T46	Quantifier_or_Qualifier 629 634	local
#43	AnnotatorNotes T46	C0205276; Local; Spatial Concept
R20	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T46	
R21	After Arg1:T30 Arg2:T31	
R22	Before Arg1:T11 Arg2:T31	
R23	Before Arg1:T29 Arg2:T30	
R24	Before Arg1:T12 Arg2:T32	
R25	Used_for Arg1:T12 Arg2:T33	
R26	Has_Age Arg1:T48 Arg2:T49	
R27	Experiences Arg1:T50 Arg2:T13	
R28	Before Arg1:T13 Arg2:T14	
R29	Before Arg1:T15 Arg2:T14	
R30	Experiences Arg1:T50 Arg2:T15	
R31	Experiences Arg1:T50 Arg2:T14	
T47	Observation 1091 1115	participar en el estudio
#44	AnnotatorNotes T47	C1278516; Patient participation status; Finding (?)
R33	Before Arg1:T16 Arg2:T47	
R34	Location_of Arg1:T35 Arg2:T17	
R35	Location_of Arg1:T34 Arg2:T17	
R36	Causes Arg1:T20 Arg2:T36	
R37	Causes Arg1:T20 Arg2:T19	
R38	Causes Arg1:T22 Arg2:T18	
R39	Causes Arg1:T22 Arg2:T21	
R40	Causes Arg1:T24 Arg2:T37	
R41	Causes Arg1:T24 Arg2:T23	
R42	Negation Arg1:T52 Arg2:T25	
T53	CONC 797 812	evitar el dolor
A12	Assertion T53 Speculated
R43	Speculation Arg1:T45 Arg2:T53	
A13	Experiencer T48 Patient
A14	Experiencer T50 Patient
A15	Experiencer T51 Patient
A16	Status T13 Future
A17	Status T14 Future
A18	Status T15 Future
